Clinical Drug Experience Knowledgebase

Alopecia (Phase 2)

Alopecia Areata (Phase 2)

Alzheimer Disease (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Atrial Fibrillation (Phase 3)

Autistic Disorder (Phase 2)

Back Pain (Phase 3)

Blepharospasm (Phase 3)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Cancer Pain (Phase 2)

Cerebral Palsy (Phase 3)

Clubfoot (Phase 2)

Cognitive Dysfunction (Phase 2)

Dementia (Phase 3)

Dementia, Vascular (Phase 3)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Disease (Phase 2)

Dystonia (Phase 4)

Dystonic Disorders (Phase 4)

Eczema (Phase 3)

Equinus Deformity (Phase 2)

Essential Tremor (Phase 2)

Facies (Phase 3)

Fasciitis (Phase 4)

Fasciitis, Plantar (Phase 4)

Glaucoma (Phase 1)

Intellectual Disability (Phase 3)

Memory Disorders (Phase 2)

Motor Neuron Disease (Phase 2)

Multiple Sclerosis (Phase 4)

Muscle Spasticity (Phase 4)

Nervous System Diseases (Phase 3)

Neuralgia (Phase 2)

Nystagmus, Congenital (Phase 2)

Nystagmus, Pathologic (Phase 2)

Paraplegia (Phase 2)

Paresis (Phase 2)

Parkinson Disease (Phase 3)

Parkinsonian Disorders (Phase 2)

Psychomotor Agitation (Phase 2)

Respiratory Aspiration (Phase 2)

Restless Legs Syndrome (Phase 2)

Rosacea (Phase 2)

Sclerosis (Phase 4)

Sialorrhea (Phase 3)

Sleep Apnea Syndromes (Phase 2)

Snoring (Phase 2)

Stroke (Phase 3)

Syndrome (Phase 2)

Talipes (Phase 2)

Thoracic Outlet Syndrome (Phase 1)

Tinea (Phase 4)

Tinea Capitis (Phase 2)

Tinea Pedis (Phase 4)

Tinnitus (Phase 3)

Torticollis (Phase 4)

Tremor (Phase 2)

Trigeminal Neuralgia (Phase 2)

Wounds and Injuries (Phase 3)